Not finding it? Sign in to also search OpenAlex live.
-
Comparative Analysis of Drugs Frequently Suspected of Causing Adverse Drug Reactions Reported via the Spontaneous Reporting System Versus in a Prospective Multicentre Cohort Study in Hospital Emergency Departments2025 Journal of Clinical Medicine article Pharmacology, Toxicology and Pharmaceutics Pharmacovigilance and Adverse Drug Reactions Open access
Verena Graeff, Markus Wehler, Harald Dormann, Julia Stingl, Katja Susanne Just, Albrecht Eisert
4citations -
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease2024 Alimentary Pharmacology & Therapeutics article Medicine Liver Disease Diagnosis and Treatment Open access
Rohit Seth Loomba, Ginger Clark, Jeffrey H. Teckman, Veeral H. Ajmera, Cynthia A. Behling, Mark Brantly, +12 more
11citations -
How to Facilitate Seamless Translation from Basic Concepts to New Heart Failure Drugs. A Scientific Statement of the Heart Failure Association of the ESC2025 European Journal of Heart Failure article Medicine Health and Medical Research Impacts Open access
Carlo Gabriele Tocchetti, Arantxa González, Johannes Backs, Piero Pollesello, Peter P. Rainer, Gabriele G. Schiattarella, +27 more
7citations -
National survey on access to new oncology drugs pending health technology assessment and financial arrangements.2021 Journal of Clinical Oncology conference-abstract Economics, Econometrics and Finance Pharmaceutical Economics and Policy
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Anke Pisters-van Roy, Haiko J. Bloemendal, Hans A. J. Gelderblom
1citations -
Comparative Analysis of Frequently Suspected Drugs for Adverse Drug Reactions in the Spontaneous Reporting System Versus in a Prospective Multicenter Cohort Study in Hospital Emergency Departments2025 Preprints.org preprint Pharmacology, Toxicology and Pharmaceutics Pharmacovigilance and Adverse Drug Reactions Open access
Verena Graeff, Markus Wehler, Harald Dormann, Julia Stingl, Katja Susanne Just, Albrecht Eisert
0citations -
Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers2021 arXiv (Cornell University) preprint Computer Science Computational Drug Discovery Methods Open access
Agastya P. Bhati, Shunzhou Wan, Austin Clyde, Mathis Bode, Mikhail Titov, André Merzky, +20 more
42citations -
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery2025 Nature Reviews Drug Discovery review Biochemistry, Genetics and Molecular Biology Receptor Mechanisms and Signaling Open access
Paolo Conflitti, Edward R. Lyman, Mark S.P. Sansom, Peter Werner Hildebrand, Hugo Gutiérrez‐de‐Terán, Paolo Carloni, +10 more
88citations -
Accelerating drug development in infectious diseases using zebrafish disease models supported by pharmacokinetic-pharmacodynamic modeling as new approach methodology (NAM)2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Zebrafish Biomedical Research Applications Open access
Gabriel Forn‐Cuní, Bart van Lieshout, Bjørn E. V. Koch, Cristina Villellas, Stijn Van Asten, Ellen A. Lanckacker, +7 more
1citations -
Fluorescence Activation Mechanism and Imaging of Drug Permeation with New Sensors for Smoking-Cessation Ligands2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Advanced Fluorescence Microscopy Techniques Open access
Aaron L. Nichols, Zack Blumenfeld, Chengcheng Fan, Laura Luebbert, Annet E. M. Blom, Bruce N. Cohen, +13 more
2citations -
Charting New Territory: Systematic Evaluation of the Drug Potential of N -Trifluoromethyl Amides, Ureas & Carbamates2026 Journal of Medicinal Chemistry article Pharmacology, Toxicology and Pharmaceutics Fluorine in Organic Chemistry Open access
Jacopo Garonzi, Gina Wycich, Stefanie Zich, Shakiba Vahdat, Beatriz Carvalho, Guillaume Benoît, +8 more
1citations -
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis2025 Blood Cancer Journal article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas, Alberto Álvarez‐Larrán, Prithviraj Bose, Robert Peter Gale, +8 more
1citations -
Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry2024 European Heart Journal article Medicine Atrial Fibrillation Management and Outcomes Open access
Bi Huang, H M Lam, Y Liu, Tze‐Fan Chao, Brian Olshansky, Menno Volkert Huisman, +1 more
1citations -
Author response: Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands2021 peer-review Biochemistry, Genetics and Molecular Biology Advanced Fluorescence Microscopy Techniques Open access
Aaron L. Nichols, Zack Blumenfeld, Chengcheng Fan, Laura Luebbert, Annet E. M. Blom, Bruce N. Cohen, +13 more
0citations -
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.2025 Research Square preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas, Alberto Álvarez‐Larrán, Prithviraj Bose, Robert Peter Gale, +9 more
0citations